[go: up one dir, main page]

ATE349513T1 - Verfahren zur homogenen masskultivierung von t- lymphozyten - Google Patents

Verfahren zur homogenen masskultivierung von t- lymphozyten

Info

Publication number
ATE349513T1
ATE349513T1 AT03776860T AT03776860T ATE349513T1 AT E349513 T1 ATE349513 T1 AT E349513T1 AT 03776860 T AT03776860 T AT 03776860T AT 03776860 T AT03776860 T AT 03776860T AT E349513 T1 ATE349513 T1 AT E349513T1
Authority
AT
Austria
Prior art keywords
lymphocytes
homogeneous mass
mass cultivation
refers
lymphocytic
Prior art date
Application number
AT03776860T
Other languages
English (en)
Inventor
Silvia Trasciatti
Maria Luisa Nolli
Luigi Cavenaghi
Bernardi Nadia De
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Application granted granted Critical
Publication of ATE349513T1 publication Critical patent/ATE349513T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • C12N5/0694Cells of blood, e.g. leukemia cells, myeloma cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT03776860T 2002-10-04 2003-10-06 Verfahren zur homogenen masskultivierung von t- lymphozyten ATE349513T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002118A ITMI20022118A1 (it) 2002-10-04 2002-10-04 Procedimento per la coltura su larga scala di t-linfociti in un sistema omogeneo.

Publications (1)

Publication Number Publication Date
ATE349513T1 true ATE349513T1 (de) 2007-01-15

Family

ID=32051228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776860T ATE349513T1 (de) 2002-10-04 2003-10-06 Verfahren zur homogenen masskultivierung von t- lymphozyten

Country Status (15)

Country Link
US (1) US7678571B2 (de)
EP (1) EP1554374B1 (de)
JP (1) JP2006500936A (de)
CN (1) CN100535107C (de)
AT (1) ATE349513T1 (de)
AU (1) AU2003286134B2 (de)
CA (1) CA2500408C (de)
DE (1) DE60310748T2 (de)
DK (1) DK1554374T3 (de)
ES (1) ES2279190T3 (de)
HK (1) HK1076294A1 (de)
IT (1) ITMI20022118A1 (de)
PT (1) PT1554374E (de)
SI (1) SI1554374T1 (de)
WO (1) WO2004031370A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101302491B (zh) * 2007-05-09 2011-09-14 王歈 高效扩增活化淋巴细胞的方法和培养系统
CA3041678A1 (en) 2016-10-26 2018-05-03 Iovance Biotherapeutics, Inc. Restimulation of cryopreserved tumor infiltrating lymphocytes
US11254913B1 (en) 2017-03-29 2022-02-22 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
JOP20190224A1 (ar) 2017-03-29 2019-09-26 Iovance Biotherapeutics Inc عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
AR112072A1 (es) 2017-06-05 2019-09-18 Iovance Biotherapeutics Inc Métodos de uso de linfocitos infiltrantes de tumor en melanoma doble refractario
SG11202006541UA (en) 2018-01-08 2020-08-28 Iovance Biotherapeutics Inc Processes for generating til products enriched for tumor antigen-specific t-cells
US11713446B2 (en) 2018-01-08 2023-08-01 Iovance Biotherapeutics, Inc. Processes for generating TIL products enriched for tumor antigen-specific T-cells
SG11202010319RA (en) 2018-04-27 2020-11-27 Iovance Biotherapeutics Inc Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
US20220090018A1 (en) 2018-11-05 2022-03-24 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes and used of the same in immunotherapy
EP4507704A1 (de) 2022-04-15 2025-02-19 Iovance Biotherapeutics, Inc. Til-expansionsverfahren unter verwendung spezifischer zytokinkombinationen und/oder einer akti-behandlung
CN115558641B (zh) * 2022-11-14 2023-05-12 四川新生命干细胞科技股份有限公司 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025572A1 (en) * 1992-06-05 1993-12-23 Synergen, Inc. T-cell monocyte inducing proteins (tmips)
PT697875E (pt) * 1993-05-14 2002-07-31 Wistar Inst Utilizacao de celulas tall-104 modificadas para tratar doencas cancerosas e virais
US5789147A (en) * 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US6022344A (en) * 1997-12-04 2000-02-08 Npbi International B.V. Cryopreservation bag

Also Published As

Publication number Publication date
AU2003286134A1 (en) 2004-04-23
DE60310748T2 (de) 2007-10-11
HK1076294A1 (en) 2006-01-13
EP1554374A1 (de) 2005-07-20
ES2279190T3 (es) 2007-08-16
EP1554374B1 (de) 2006-12-27
WO2004031370A1 (en) 2004-04-15
CA2500408C (en) 2015-02-17
DK1554374T3 (da) 2007-05-07
US20060034802A1 (en) 2006-02-16
AU2003286134B2 (en) 2008-10-16
CN1703506A (zh) 2005-11-30
PT1554374E (pt) 2007-03-30
DE60310748D1 (de) 2007-02-08
SI1554374T1 (sl) 2007-06-30
CA2500408A1 (en) 2004-04-15
US7678571B2 (en) 2010-03-16
JP2006500936A (ja) 2006-01-12
CN100535107C (zh) 2009-09-02
ITMI20022118A1 (it) 2004-04-05

Similar Documents

Publication Publication Date Title
DK1451290T3 (da) Indretning og fremgangsmåde til udførelse af fermentering af høj celledensitet
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
DK1664318T3 (da) L-aminosyre-producerende mikroorganisme og fremgangsmåde til fremstilling af L-aminosyre
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
ATE452664T1 (de) Verfahren und vorrichtung zum züchten von zellen
BR122019022434B8 (pt) método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
SG158025A1 (en) Growth medium c. histolyticum without ingredients of mamalian sources
NO20072719L (no) Serumfritt cellekulturmedium for pattedyrceller
ATE414144T1 (de) Kulturen von e1-immortalisierten zellen und verfahren zu deren kultivierung zur erhöhung der produktausbeuten davon
ATE349513T1 (de) Verfahren zur homogenen masskultivierung von t- lymphozyten
AU2003252396A1 (en) APPARATUS FOR ENVIRONMENT OF CULTIVATING/CULTURING PLANT, CULTIVATION/CULTURE METHOD and CULTIVATION/CULTURE APPARATUS
DE60307615D1 (de) Zellkulturmedium
HK1070820A1 (en) Methods for the in vitro culture of sporozoea sp. and use thereof
EP1541670A4 (de) MIKROKAMMER FüR NERVENZELLKULTUR
EA200702050A1 (ru) Способ микробиального производства ценного соединения
WO2018183848A8 (en) Media for microorganism culture and related compositions and methods
EP3967753A4 (de) Verfahren zur züchtung allogener immunzellen, dadurch erhaltene immunzellenkultur und immunzellentherapeutikum damit
EP1517987A4 (de) Lungenzellen von baumwollratten zur virenkultur
ATE384121T1 (de) Verfahren zur kultivierung von menschlichen lungenmastzellen und deren anwendungen
ATE313622T1 (de) Verfahren zur züchtung von haftenden tierischen zellen
IL179318A (en) Methods for cultivating stem cells, cell cultures and the use of an egg for the cultivation of the stem cells
DE60314904D1 (de) Verfahren zur herstellung von chinoloncarboxylat-derivaten
ATE334209T1 (de) Inaktivierung von genen des mep-wegs
DE10393303D2 (de) Kultursysteme zur sterilen kontinuierlichen Kultivierung von Zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1554374

Country of ref document: EP